Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2015 Feb 7;2015:bcr2014207054. doi: 10.1136/bcr-2014-207054

Ackerman syndrome: a rare cause of arthritis with dermatitis

Kosar Hussain 1, Liza Thomas 1, Niaz Ahmed Shaikh 1, Badr Ahmed Abdul Hamid 2
PMCID: PMC4330410  PMID: 25666244

Abstract

We present a case of a middle-aged woman who presented with acute onset of non-erosive oligoarthritis and cutaneous lesions. Her laboratory work up revealed mild anaemia with positive antinuclear antibody. Her skin biopsy confirmed the presence of interstitial granulomatous dermatitis. She was treated with a successful trial of non-steroidal anti-inflammatory agents. Interstitial granulomatous dermatitis with arthritis (IGDA), or Ackerman syndrome, is an under-recognised cause of arthritis with dermatitis. This is primarily due to the varied clinical presentation of the skin lesions and the non-specific laboratory findings. Our aim is to highlight the pivotal role of skin biopsy as part of the diagnostic assessment of patients who present with arthritis and concomitant skin lesions.

Background

Ackerman syndrome is an uncommon and under-recognised cause of arthritis with dermatitis. It is associated with various autoimmune conditions. The clinical and laboratory findings are mainly non-specific, and the most important diagnostic tool for this condition is a skin biopsy.

Case presentation

A 35-year-old Indian woman with no significant medical history presented with a 1-week history of low-grade fever, dysuria, yellow-mucoid vaginal discharge, rash, oral ulcers and left knee joint swelling. There was no ocular involvement. There was no preceding history of diarrhoea or flu-like illness. There was no history of joint pain, myalgia, photosensitive rash, alopecia, venous thromboembolism episodes, obstetric complications, haematological or renal diseases. She did not have any preceding constitutional symptoms such as weight loss, night sweats, chronic fever, cough or haemoptysis prior to the onset of this episode of illness. She denied any recent use of medications. There was no history of recent travel or contact with anyone ill. She was married with two children. She was a strict vegetarian, non-smoker and denied alcohol consumption.

On examination, the patient's vital signs were as follows: temperature 37.2°C, blood pressure 120/70 mm Hg, heart rate 86 bpm, respiratory rate 18 bpm and oxygen saturation by pulse oximetry 100% in room air. Her left knee and ankle were warm, swollen and tender. There was no calf tenderness present. Dermatological assessment revealed the presence of symmetrically-distributed indurated erythematous to violaceous annular plaques all over her body surface, excluding the palms and soles. The plaques were non-tender, non-pruritic, had well-demarcated borders and measured 1–2 cm (figure 1). She also had oral ulcers present in her inner lip and buccal cavity. Ophthalmological examination was normal. Other systemic examinations, including a pelvic examination, were unremarkable.

Figure 1.

Figure 1

Image of right upper extremity (A) and bilateral lower extremities (B) of the patient showing the skin lesions.

Investigations

The laboratory work up for the patient is given in table 1.

Table 1.

Results of the laboratory investigation

Laboratory parameter Patient's result
WCC 4.8×103/μL
Hb 11.1 g/dL
(normocytic normochromic)
Platelet 255×103/μL
Ferritin 64 ng/mL
PT 12 s (11–14), INR 1.1
APTT 30 s (28–41)
D-dimer 0.68 mg/L (<0.5)
ESR 38 mm/1 h
CRP 40 mg/dL
PCT 0.04 pg/mL
Blood culture ×2 Negative
Liver function test Normal
Renal function test Cr 0.5 mg/dL, Urea 11 mg/dL, electrolytes: normal
Urine analysis: 10-15 WCC, few epithelial cells, no casts, proteinuria or RBC
Urine culture: negative
Uric acid 1.7 mg/dL
CPK 59
Thyroid function test Normal
HBA1c 6.4%
HIV, HBsAg, HCV, VDRL Negative
High vaginal swab 2-4 WCC/hpf
Epithelial cells/hpf: 2+
No pathogen isolated
Knee aspirate Yellowish turbid fluid
Blood: not visible
Coagulum: not visible
WCC count/cm2: 2000 (75% lymphocyte)
RBC count/cm2: 100
Gram stain: no organisms seen
Culture: negative
T-spot test Indeterminate
Mantoux skin test <5 mm induration
Autoantibodies Antidouble stranded DNA Ab: negative
ANA: positive, 1/80 speckled pattern
Rheumatoid factor, anti-CCP: negative
c-ANCA, p-ANCA: negative
Antiphospholipid Ab, anticardiolipin, β 2 glycoprotein: negative

ANA, antinuclear antibody; APTT, activated partial thromboplastin time; c-ANCA, cytoplasmic antineutrophil cytoplasmic autoantibody; CPK, creatine phosphokinase; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; HBA1c, glycated haemoglobin; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; hpf, high power field; INR, international normalised ratio; p-ANCA, perinuclear antineutrophil cytoplasmic autoantibody; RBC, red blood cell; VDRL, Venereal Disease Research Laboratory WCC, white cell count.

Chest, abdomen and pelvis imaging was reported as normal. Ultrasound Doppler of the lower limbs did not show any sign of deep vein thrombosis.

Ultrasound scan of the neck showed multiple well-defined, oval shaped and hypoechoic bilateral cervical lymph nodes with normal echogenic hilum. The thyroid gland was normal. The patient was offered excisional lymph node biopsy, however, she refused to undergo the procedure at that time.

A skin punch biopsy was taken from one of the skin lesions.

Differential diagnosis

  • Reactive arthritis

  • Disseminated gonococcal infection

  • Systemic lupus erythaematosus

  • Rheumatoid arthritis

Treatment

As the knee aspirate was not suggestive of septic arthritis, the initial clinical impression was reactive arthritis or disseminated gonococcal infection. The patient was therefore empirically treated with a course of ceftriaxone and azithromycin along with non-steroidal anti-inflammatory drugs. During the course of hospital stay her left ankle also became painful and swollen.

Later, the result of the skin biopsy returned, showing diffuse interstitial granulomatous dermatitis with lichenoid interface dermatitis (figure 2). The epidermis showed a maintained basket weave horny layer and foci of parakeratosis mounds without neutrophils. The basal layer showed foci of interface dermatitis with vacuolar degeneration, spongiosis, few necrotic keratinocytes and lymphocytic exocytosis. The basement membrane was not thickened. The papillary dermis showed mild oedema, pigment incontinence and scant extravasated red blood cells. The papillary and deeper dermis showed scattered foci at different levels of ill-defined necrotising interstitial epithelioid granulomas composed of epithelioid histiocytes with debris karyorrhectic material, lymphocytes and few neutrophils (figure 3). They involved the interstitial collagen bundles with minimal necrobiosis, smooth muscle bundles and tissue around sweat ducts/glands. No eosinophils, plasma cells or giant cells were seen. The small blood vessels were intact overall. There was no evidence of fibrin thrombi. The panniculus-dermis interface was focally involved by non-specific chronic inflammation, probably secondary to the adjacent dermis. The subcutaneous fat tissue was, otherwise, uninvolved. Mucin stains (Colloid iron and Alcian blue) showed minimal mucin deposition in and around granulomatous collections. The larger blood vessels were intact and uninvolved. Special stains for acid-fast bacilli (ZN and Fite) and for fungi (PAS and GMS) were negative.

Figure 2.

Figure 2

Low-power view of the skin punch biopsy (×40) of the epidermis, dermis and panniculus.

Figure 3.

Figure 3

High-power view (×400) of the reticular dermis.

The patient was discharged on a 4-week course of a non-steroidal anti-inflammatory agent.

Outcome and follow-up

The patient was followed-up after a month. She reported that the arthritis had improved significantly and the rash had acquired a faint brown macular appearance. The cervical lymph nodes were not palpable.

Discussion

Interstitial granulomatous dermatitis (IGD) belongs to a subgroup of non-infectious granulomatoses. It is a distinct histopathological entity that is associated with a number of autoimmune conditions, including rheumatoid arthritis,1 systemic lupus erythaematosus,2–6 autoimmune thyroiditis,7 antiphospholipid syndrome,8 etc. It is, therefore, postulated to have an immune-mediated aetiology.9 There are a few isolated case reports linking IGD to underlying malignancies.10 11

When IGD occurs in association with arthritis, it is known as interstitial granulomatous dermatitis with arthritis (IGDA), or Ackerman syndrome. This uncommon condition was initially described by Ackerman in 1993.12 His description initiated a series of case reports that described similar patients. IGDA typically affects middle-aged women. The dermatological manifestations are extremely variable and include multiple, symmetric, erythematous to violaceous papules, nodules or plaques. However, the hallmark of this condition is the characteristic ‘rope-sign’, in the form of palpable subcutaneous linear cords that typically occur in the axilla. Nevertheless, this finding occurs only in a minor subgroup of patients.13 The joint manifestation is commonly in the form of non-erosive, seronegative arthritis or arthralgia; this may occur at any stage of cutaneous manifestation, that is, prior to, during or even after the onset of dermatological eruptions.9 The laboratory abnormalities include ANA positivity, elevated ESR, mild anaemia and leucopaenia.13

Owing to the rarity of the condition, the experience for treatment of IGDA is not well established and response to various therapeutic agents is limited to scattered case reports in the literature. The associated conditions, for example, SLE or rheumatoid arthritis, could have a significant role in influencing the choice of agents. Treatment options include non-steroidal anti-inflammatory drugs,14 topical steroids,13 15 systemic steroids6 16 17 or any combination of these agents.8 18 Other available options for more resistant cases include methotrexate,19 anti-TNF agents,20 21 toclizumab,22 ustekinumab23 and IVIG.24 Nevertheless, the specific indication for each class of therapeutic agent is still not clearly defined.

The prognosis of IGDA is variable. At times it could be a self-limiting condition with a documented spontaneous resolution.25 On the other hand, it may have an undulating course with frequent flares that are resistant to various therapeutic agents.9

Learning points.

  • In patients with skin and joint manifestations, skin biopsy is a valuable diagnostic intervention.

  • Consider the possibility of interstitial granulomatous dermatitis with arthritis (IGDA), or Ackerman syndrome, in the differential diagnosis of cutaneous lesions with arthritis.

  • Owing to association of IGDA with other autoimmune conditions, a full work up for underlying autoimmune or malignancy is warranted.

Footnotes

Contributors: KH wrote the manuscript. LT and NAS reviewed the manuscript. BAAH reviewed the histopathological details of the case. All authors reviewed and approved the final version.

Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Hu S, Cohen D, Murphy G et al. Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept. Cutis 2008;81:336–8. [PubMed] [Google Scholar]
  • 2.García-Rabasco A, Esteve-Martínez A, Zaragoza-Ninet V et al. Interstitial granulomatous dermatitis in a patient with lupus erythematosus. Am J Dermatopathol 2011;33:871–2. 10.1097/DAD.0b013e31820d171c [DOI] [PubMed] [Google Scholar]
  • 3.Gulati A, Paige D, Yaqoob M et al. Palisaded neutrophilic granulomatous dermatitis associated with systemic lupus erythematosus presenting with the burning rope sign. J Am Acad Dermatol 2009;61:711–14. 10.1016/j.jaad.2008.12.016 [DOI] [PubMed] [Google Scholar]
  • 4.Marmon S, Robinson M, Meehan SA et al. Lupus-erythematous-associated interstitial granulomatous dermatitis. Dermatol Online J 2012;18:31. [PubMed] [Google Scholar]
  • 5.Wong HK, Kaffenberger BH, Zirwas M. A palpable erythematous cord over the trunk in a patient with systemic lupus erythematosus. Interstitial granulomatous dermatitis (IGD). JAMA Dermatol 2013;149:609–14. 10.1001/jamadermatol.2013.2647a [DOI] [PubMed] [Google Scholar]
  • 6.Blaise S, Salameire D, Carpentier PH. Interstitial granulomatous dermatitis: a misdiagnosed cutaneous form of systemic lupus erythematosus? Clin Exp Dermatol 2008;33:712–14. 10.1111/j.1365-2230.2008.02774.x [DOI] [PubMed] [Google Scholar]
  • 7.Antunes J, Pacheco D, Travassos AR et al. Autoimmune thyroiditis presenting as interstitial granulomatous dermatitis. An Bras Dermatol 2012;87:748–51. 10.1590/S0365-05962012000500013 [DOI] [PubMed] [Google Scholar]
  • 8.Lee HW, Chang SE, Lee MW et al. Interstitial granulomatous dermatitis with plaques associated with antiphospholipid syndrome. Br J Dermatol 2005; 152:814–16. 10.1111/j.1365-2133.2005.06505.x [DOI] [PubMed] [Google Scholar]
  • 9.Verneuil L, Dompmartin A, Comoz F et al. Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies. J Am Acad Dermatol 2001;45:286–91. 10.1067/mjd.2001.114577 [DOI] [PubMed] [Google Scholar]
  • 10.Schreckenberg C, Asch PH, Sibilia J et al. [Interstitial granulomatous dermatitis and paraneoplastic rheumatoid polyarthritis disclosing cancer of the lung]. Ann Dermatol Venereol 1998;125:585–8. [PubMed] [Google Scholar]
  • 11.Swing DC Jr, Sheehan DJ, Sangüeza OP et al. Interstitial granulomatous dermatitis secondary to acute promyelocytic leukemia. Am J Dermatopathol 2008;30:197–9. 10.1097/DAD.0b013e318162af78 [DOI] [PubMed] [Google Scholar]
  • 12.Ackerman AB, Guo Y, Vitale P et al. Clues to diagnosis in dermatopathology, Vol 3 Chicago: ASCP Press, 1993:309–12. [Google Scholar]
  • 13.Peroni A, Colato C, Schena D et al. Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern. Br J Dermatol 2012;166:775–83. 10.1111/j.1365-2133.2011.10727.x [DOI] [PubMed] [Google Scholar]
  • 14.Comte C, Guillot B, Durand L et al. [Interstitial granulomatous dermatitis with arthritis: four cases]. Ann Dermatol Venereol 2008;135:38–43. 10.1016/j.annder.2007.04.003 [DOI] [PubMed] [Google Scholar]
  • 15.Warycha MA, Fangman W, Kamino H et al. Interstitial granulomatous dermatitis in a child with chronic uveitis. J Am Acad Dermatol 2008;58(5 Suppl 1):S100–2. 10.1016/j.jaad.2007.03.015 [DOI] [PubMed] [Google Scholar]
  • 16.Long D, Thiboutot DM, Majeski JT et al. Interstitial granulomatous dermatitis with arthritis. J Am Acad Dermatol 1996;34:957–61. 10.1016/S0190-9622(96)90272-8 [DOI] [PubMed] [Google Scholar]
  • 17.Lee KJ, Lee ES, Lee DY et al. Interstitial granulomatous dermatitis associated with autoimmune hepatitis. J Eur Acad Dermatol Venereol 2007;21:684–5. [DOI] [PubMed] [Google Scholar]
  • 18.Bañuls J, Betlloch I, Botella R et al. Interstitial granulomatous dermatitis with plaques and arthritis. Eur J Dermatol 2003;13:308–10. [PubMed] [Google Scholar]
  • 19.Dubey S, Merry P. Clinical vignette. Interstitial granulomatous dermatitis (Ackerman's syndrome) in SLE presenting with the ‘rope sign’. Rheumatology (Oxford) 2007;46:80 10.1093/rheumatology/kel264 [DOI] [PubMed] [Google Scholar]
  • 20.Ahmed ZS, Joad S, Singh M et al. Interstitial granulomatous dermatitis successfully treated with etanercept. Am J Case Rep 2014;15:94–6. 10.12659/AJCR.890074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zoli A, Massi G, Pinnelli M et al. Interstitial granulomatous dermatitis in rheumatoid arthritis responsive to etanercept. Clin Rheumatol 2010;29:99–101. 10.1007/s10067-009-1287-8 [DOI] [PubMed] [Google Scholar]
  • 22.Schanz S, Schmalzing M, Guenova E et al. Interstitial granulomatous dermatitis with arthritis responding to tocilizumab. Arch Dermatol 2012;148:17–20. 10.1001/archdermatol.2011.341 [DOI] [PubMed] [Google Scholar]
  • 23.Leloup P, Aubert H, Causse S et al. Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis. JAMA Dermatol 2013;149:626–7. 10.1001/jamadermatol.2013.256 [DOI] [PubMed] [Google Scholar]
  • 24.Alghamdi R, Bejar C, Steff M et al. Intravenous immunoglobulins as a treatment of interstitial granulomatous dermatitis with arthritis. Br J Dermatol 2012;167:218–20. 10.1111/j.1365-2133.2012.10854.x [DOI] [PubMed] [Google Scholar]
  • 25.Aloi F, Tomasini C, Pippione M. Interstitial granulomatous dermatitis with plaques. Am J Dermatopathol 1999;21:320–3. 10.1097/00000372-199908000-00002 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES